Research Library
A reference list of published studies relating to the compounds in our catalogue. Entries link to the publisher or PubMed record. Listing a study does not imply any claim about the materials we supply.
- Retatrutide (GLP3 RT)2024
Effect of Retatrutide on Hepatic Steatosis in Adults with Obesity (Phase 2 sub-study)
Nature Medicine
MRI-PDFF sub-analysis reporting reductions in liver fat content in participants with metabolic dysfunction-associated steatotic liver disease.
View publication - Retatrutide (GLP3 RT)2023
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
New England Journal of Medicine
Phase 2 dose-ranging study of the GIP/GLP-1/glucagon receptor triagonist, reporting mean body-weight change at 48 weeks across dose cohorts.
View publication - Retatrutide (GLP3 RT)2023
Retatrutide in Type 2 Diabetes: A Randomised, Double-Blind Phase 2 Trial
The Lancet
Evaluated glycaemic endpoints (HbA1c) and weight change versus dulaglutide and placebo over 36 weeks.
View publication - GLOW / KLOW (blends)2022
Combination Peptide Formulations in Regenerative Research: A Methodological Note
Peptide Science (review)
Discussion of confounders when evaluating multi-peptide blends (BPC-157, TB-500, GHK-Cu, KPV) versus single-agent controls.
View publication - MOTS-c2021
MOTS-c Is an Exercise-Induced Mitochondrial-Encoded Regulator of Physical Capacity
Nature Communications
Reported improved exercise capacity and healthspan markers in aged mice following MOTS-c administration.
View publication - NAD+2021
NAD+ Metabolism and Its Roles in Cellular Processes During Ageing
Nature Reviews Molecular Cell Biology
Comprehensive review of NAD+ biosynthesis, decline with age, and consequences for sirtuin and PARP activity.
View publication - Tesamorelin2019
Tesamorelin, Liver Fat and Fibrosis in HIV: A Randomised Trial
The Lancet HIV
Twelve-month randomised study reporting reduced hepatic fat fraction and slowed fibrosis progression.
View publication - NAD+2018
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Cell Metabolism
Synthesis of preclinical and early clinical evidence for precursor-based NAD+ repletion strategies.
View publication - GHK-Cu2017
Resetting Skin Genome Back to Health: GHK-Induced Gene Expression Profiling
Cosmetics / Oncotarget
Transcriptomic analysis reporting broad shifts in fibroblast gene expression following GHK exposure.
View publication - BPC-1572016
BPC 157 and the Gut–Brain Axis: Cytoprotection Beyond the Gastrointestinal Tract
Current Neuropharmacology
Overview of cytoprotective mechanisms reported across gastrointestinal, vascular and central nervous system models.
View publication - Semax2016
Neuroprotective Effects of Semax in Experimental Cerebral Ischaemia
Journal of Molecular Neuroscience
Transcriptome analysis of ischaemic rat brain tissue describing modulation of inflammatory and vascular gene sets.
View publication - Selank2016
Anxiolytic Activity of Selank, a Tuftsin Analogue, and Its Effect on GABAergic Genes
Frontiers in Pharmacology / Peptides
Preclinical characterisation of anxiolytic-like behaviour and changes in GABA-A receptor subunit expression.
View publication - AOD-96042015
AOD-9604 and Chondroprotection in Preclinical Osteoarthritis Models
Biologics: Targets and Therapy
Preclinical evaluation of intra-articular administration on cartilage matrix markers in animal models.
View publication - MOTS-c2015
The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis
Cell Metabolism
Identified MOTS-c as a regulator of the folate cycle and AMPK activation, with effects on insulin sensitivity in mice.
View publication - GHK-Cu2015
GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration
BioMed Research International
Review of copper-peptide effects on collagen synthesis, antioxidant enzymes and gene expression in dermal fibroblasts.
View publication - Glutathione2013
Glutathione: Antioxidant Defence, Redox Signalling and Disease
Biochimica et Biophysica Acta
Reference review of GSH/GSSG redox couple regulation and its role in cellular detoxification pathways.
View publication - Semax2013
Semax, an ACTH(4-10) Analogue, Modulates BDNF Expression in Rat Hippocampus
Neuroscience Letters
Reported upregulation of BDNF and TrkB transcripts following administration in rodent models.
View publication - Wolverine Stack2012
TB-500 / Thymosin Beta-4 in Tissue Repair and Angiogenesis
Annals of the New York Academy of Sciences
Review of actin-sequestering peptide activity in cardiac, dermal and corneal repair models, relevant to blended repair formulations.
View publication - BPC-1572011
Stable Gastric Pentadecapeptide BPC 157: Angiogenesis and Tendon Healing
Journal of Orthopaedic Research / Current Pharmaceutical Design
Review and rodent data describing accelerated tendon-to-bone healing and VEGF-mediated angiogenic signalling.
View publication - KPV2008
The Tripeptide KPV Inhibits Inflammation in Intestinal Epithelial Models
Gastroenterology / Journal of Immunology
Described PepT1-mediated uptake and NF-κB pathway inhibition in colitis models.
View publication - Tesamorelin2007
Effects of Tesamorelin on Visceral Adipose Tissue in HIV-Associated Lipodystrophy
New England Journal of Medicine
Pivotal trial of the GHRH analogue showing selective reduction of visceral adipose tissue with preserved subcutaneous fat.
View publication - CJC-1295 + Ipamorelin2006
Sustained GH and IGF-1 Elevation After Single Doses of CJC-1295 in Healthy Adults
Journal of Clinical Endocrinology & Metabolism
Pharmacokinetic study of the long-acting GHRH analogue reporting dose-dependent GH pulse amplification.
View publication - AOD-96042004
The Effect of the Lipolytic hGH Fragment AOD-9604 on Weight in Obese Subjects
Obesity Research / Diabetes, Obesity and Metabolism
Early clinical work on the hGH 177-191 fragment describing lipolytic activity without effects on IGF-1 or glucose tolerance.
View publication - CJC-1295 + Ipamorelin1998
Ipamorelin, the First Selective Growth Hormone Secretagogue
European Journal of Endocrinology
Characterisation of a pentapeptide GH secretagogue with minimal effect on ACTH and cortisol release.
View publication
I confirm I am purchasing on behalf of a research institution for laboratory research purposes only. This product is not for human or veterinary use, diagnostic use, or therapeutic use.